Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

PHASE2UnknownINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Decompensated Cirrhosis
Interventions
DRUG

Emricasan (25 mg)

25 mg emricasan

DRUG

Emricasan (5 mg)

5 mg emricasan

DRUG

Placebo

Matching Placebo

Trial Locations (76)

10016

NYU Medical Center, New York

10021

Weill Cornell Medical College, New York

10032

Columbia University Medical Center - Center for Liver Disease and Transplantation, New York

11030

Northwell Health Inc., Sandra Atlas Bass Center for Liver Diseases., Manhasset

14642

University of Rochester Medical Center, Rochester

19104

Hospital of the University of Pennsylvania, Philadelphia

20176

Emeritas Research Group LLC, Leesburg

20889

Walter Reed National Military Medical Center (WRNMMC), Bethesda

21202

Mercy Medical Center, Baltimore

21228

Digestive Disease Associates, PA, Catonsville

22908

University of Virginia, Charlottesville

23226

Bon Secours Liver Institute of Virginia, Richmond

23298

Virginia Commonwealth University, Richmond

23602

Banner University Medical Center - Phoenix Transplant Institute, Newport News

27710

Duke University Medical Center, Durham

28204

Carolinas Healthcare System, Center for Liver Disease, Charlotte

28557

Diabetes & Endocrinology Consultants, PC, Morehead City

29425

Medical University of South Carolina, Charleston

29605

GHS Gastroenterology and Liver Center, Greenville

30060

Gastrointestinal Specialists of Georgia, Marietta

30309

Piedmont Transplant Institute, Atlanta

32224

Mayo Clinic, Jacksonville

32610

UF Hepatology Research at CTRB, Gainesville

32804

Florida Hospital Transplant Institute, Orlando

33136

Schiff Center for Liver Disease/University of Miami, Miami

33157

IMIC Inc., Palmetto Bay

33606

Tampa General Hospital, Tampa

34211

Florida Research Institute, Lakewood Rch

37232

Vanderbilt University Medical Center, Nashville

37421

ClinSearch, LLC, Chattanooga

39216

University of Mississippi Medical Center, Division of Digestive Diseases, Jackson

45267

UC Health/ UCPC LLC, Cincinnati

46202

Indiana University, Indianapolis

47150

Aquiant Research, Albany

48202

Henry Ford Health System, Detroit

52242

University of Iowa Hospitals and Clinics/ Internal Medicine, Iowa City

55901

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

64131

Kansas City Research Institute, Kansas City

70121

Ochsner Clinic Foundation, New Orleans

71220

Delta Research Partners, Bastrop

74104

Options Health Research, LLC, Tulsa

75203

Methodist Health System Clinical Research Institute, Dallas

75390

University of Texas Southwestern Medical Center, Dallas

76012

Texas Clinical Research Institute, Arlington

76104

Baylor Scott & White Research Institute, Fort Worth

77030

Baylor College of Medicine - Advanced Liver Therapies, Houston

Liver Associates of Texas, P.A., Houston

78215

American Research Corporation at the Texas Liver Institue, San Antonio

78229

Methodist Specialty & Transplant Hospital, San Antonio

78234

San Antonio Military Medical Center, San Antonio

80045

University of Colorado Denver, Aurora

80907

Peak Enterology Associates, Colorado Springs

84132

University of Utah, Salt Lake City

85013

St. Joseph's Hospital & Medical Center, Phoenix

85054

Mayo Clinic Arizona, Phoenix

85224

The Institute for Liver Health, Chandler

85747

University of Arizona Liver Research Institute, Tucson

90048

Cedars Sinai Medical Center, Los Angeles

90095

UCLA Pfleger Liver Institute, Los Angeles

91105

California Liver Research Institute, Pasadena

92037

Scripps Clinic - Torrey Pines, San Diego

92377

Inland Empire Liver Foundation, Rialto

93701

University of California, San Francisco-Fresno, Fresno

94063

Stanford University, Redwood City

94115

California Pacific Medical Center, San Francisco

94143

University of California San Francisco, San Francisco

95817

UC Davis GI/Hepatology Clinical Trials Unit, Sacramento

98104

Swedish Organ Transplant and Liver Center, Seattle

University of Washington Harborview Medical Center, Seattle

98195

University of Washington, Seattle

06516

West Haven VA Medical Center, West Haven

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

07103

Rutgers New Jersey Medical School, Newark

Sponsors
All Listed Sponsors
lead

Conatus Pharmaceuticals Inc.

INDUSTRY

NCT03205345 - Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis | Biotech Hunter | Biotech Hunter